How Huinno CEO Yeongjoon Gil grew to $15.1M revenue with a 61 person team in 2023.

HUINNO, a forefront leader in the digital healthcare market, was established in 2014. It is a pioneering healthcare startup specializing in the development of wearable technologies, notably the MEMO Watch and MEMO Patch, which are innovative solutions for cardiac monitoring. These devices incorporate cutting-edge AI-based cloud analysis software, enabling easy, convenient, and cost-efficient diagnosis and treatment of cardiac conditions such as arrhythmia, atrial fibrillation, and hypertension, conditions that conventional medical devices often struggle to diagnose effectively.

The products offered by HUINNO, including the MEMO Watch, MEMO Patch, and their proprietary MEMO AI technology, have substantially impacted the healthcare industry. HUINNO has initiated services in collaboration with esteemed institutions such as Seoul National University Hospital, Korea University Hospital, and Yuhan Corp, marking significant milestones in its journey toward revolutionizing cardiac care.

HUINNO's technology arsenal is twofold. Firstly, MEMO AI is an advanced AI-based biosignal analysis solution that interprets a variety of biosignals, such as ECG (electrocardiogram), oxygen saturation, and heart rate, to provide critical diagnostic information for arrhythmia and hypertension. This solution, which leverages a database of up to 400,000 patients, achieves an ECG reading precision of 97%, significantly outperforming traditional algorithms, which hover around a 70% accuracy rate. MEMO AI presents a substantial advancement in increasing diagnosis precision, saving considerable time in ECG data screening and diagnosis, and substantially enhancing the efficiency of medical services.

The second strand of HUINNO's technological innovation is the development of devices capable of conveniently measuring and monitoring a range of biosignals over extended periods. These devices come in various forms to best meet the needs of users and are equipped with ultra-low power technology, allowing for long-term use without the need for frequent recharging. This versatility in device form factor, combined with the extended use capability, underscores HUINNO's commitment to user-centered design and practicality in healthcare monitoring.

In essence, HUINNO stands as a beacon of innovation in the digital healthcare market, offering solutions that bridge the gap between advanced technology and practical healthcare needs. Through its revolutionary products and services, HUINNO not only facilitates fast and affordable diagnosis and treatment of cardiac diseases but also champions a new era of patient-centric healthcare.